Company Sector
CNS
CNS refers to central nervous system diseases such as depression, schizophrenia, epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological or psychiatric conditions. Companies on this page are grouped by their exposure to brain and nervous system therapeutics.
Why watch CNS
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest CNS news
The latest feed items from companies currently grouped under CNS.
- 01
- 02
TNXPTonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®
Source: Tonix Pharmaceuticals
- 03
ALNYAlnylam to Webcast Presentations at Upcoming Investor Conferences
Source: Alnylam Pharmaceuticals, Inc.
- 04
ALNYNew Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutris
Source: Alnylam Pharmaceuticals, Inc.
- 05
ALNYAlnylam Issues 2025 Corporate Responsibility Report
Source: Alnylam Pharmaceuticals, Inc.
- 06
ALNYAlnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
Source: Alnylam Pharmaceuticals, Inc.
- 07
ALNYAlnylam to Host Tenth “RNAi Roundtable” Webcast Series
Source: Alnylam Pharmaceuticals, Inc.
- 08
TEVATeva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (
Source: Teva Pharmaceutical Industries
- 09
KTTAPasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Source: Pasithea Therapeutics
- 10
TEVATeva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Viti
Source: Teva Pharmaceutical Industries
- 11
ACADAcadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
Source: ACADIA Pharmaceuticals Inc.
- 12
NRSNNeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"
Source: NeuroSense Therapeutics
- 13
- 14
- 15
- 16
SRPTSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Sarepta Therapeutics
- 17
SRPTSarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
Source: Sarepta Therapeutics
- 18
- 19
- 20
Companies in CNS
52 companies tagged with CNS.
Frequently Asked Questions
What does the CNS sector include?
CNS refers to central nervous system diseases such as depression, schizophrenia, epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological or psychiatric conditions. Companies on this page are grouped by their exposure to brain and nervous system therapeutics.
How many companies are currently tagged with CNS?
52 companies are currently grouped under CNS on BioPharmSignal.
Which companies are most visible in the CNS group right now?
ABBV, ACIU, ACAD, ALNY are among the companies currently shown on this sector page.
How can I watch news for CNS?
Use the Watch button on this page to subscribe to CNS headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for CNS?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in CNS.